These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3052138)

  • 21. Open label study of alprazolam in severely depressed inpatients.
    Feighner JP
    J Clin Psychiatry; 1983 Sep; 44(9):332-4. PubMed ID: 6138346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial.
    Gatto G; Caleri D; Michelacci S; Sicuteri F
    Int J Clin Pharmacol Res; 1986; 6(1):15-7. PubMed ID: 3514492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled clinical study of SAMe (S-adenosylmethionine) administered orally in degenerative osteoarticular pathology].
    Cucinotta D; Mancini M; Ceccato S; Castino E
    G Clin Med; 1980 Jul; 61(7):553-66. PubMed ID: 7004982
    [No Abstract]   [Full Text] [Related]  

  • 25. [S-adenosylmethionine (SAMe) in osteoarthrosis; a double-blind crossover peroral study].
    Pellegrini P
    G Clin Med; 1980 Aug; 61(8):616-27. PubMed ID: 7004985
    [No Abstract]   [Full Text] [Related]  

  • 26. The antidepressant potential of oral S-adenosyl-l-methionine.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Acta Psychiatr Scand; 1990 May; 81(5):432-6. PubMed ID: 2113347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating depressions of bereavement with antidepressants. A pilot study.
    Jacobs SC; Nelson JC; Zisook S
    Psychiatr Clin North Am; 1987 Sep; 10(3):501-10. PubMed ID: 3684751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of postconcussion syndrome with S-adenosylmethionine].
    Bacci Ballerini F; López Anguera A; Alcaraz P; Hernández Reyes N
    Med Clin (Barc); 1983 Feb; 80(4):161-4. PubMed ID: 6345953
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy and therapeutic factors of interpersonal psychotherapy for depressed inpatients - results of a pilot study].
    Schramm E; van Calker D; Berger M
    Psychother Psychosom Med Psychol; 2004 Feb; 54(2):65-72. PubMed ID: 14872393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of isocarboxazid and haloperidol to alleviate delusional depression in a pilot study.
    Davidson J; Miller R; Wingfield M; Dougherty G
    J Clin Psychopharmacol; 1982 Dec; 2(6):408-11. PubMed ID: 7174864
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with clomipramine (Hydiphen) and desipramine (Petytyl) by parenteral administration in the treatment of endogenous depression with signs of pharmacoresistance].
    Cesková E; Náhunek K; Rysánek R; Svestka J
    Cesk Psychiatr; 1983 Apr; 79(2):94-101. PubMed ID: 6345009
    [No Abstract]   [Full Text] [Related]  

  • 32. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pyrazidole in the treatment of endogenous depression: controlled study (author's transl)].
    Zapletálek M; Libiger J; Kaspárková E; Tůma I; Domkár J
    Cesk Psychiatr; 1981 Feb; 77(1):31-7. PubMed ID: 7018710
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new treatment for depression: S-adenosylmethionine. An international symposium. Trieste, Italy, June 18, 1987. Proceedings.
    Ala J Med Sci; 1988 Jul; 25(3):291-319. PubMed ID: 3177803
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance phenelzine treatment of major depression: an interim report.
    Robinson DS; Kayser A; Bennett B; Devereaux E; Lerfald SC; Albright D; Laux D; Corcella J
    Psychopharmacol Bull; 1986; 22(3):553-7. PubMed ID: 3099323
    [No Abstract]   [Full Text] [Related]  

  • 39. Low-dose fluoxetine therapy for depression.
    Wernicke JF; Dunlop SR; Dornseif BE; Bosomworth JC; Humbert M
    Psychopharmacol Bull; 1988; 24(1):183-8. PubMed ID: 3290940
    [No Abstract]   [Full Text] [Related]  

  • 40. Summaries of the Sixth Annual Poster Session of the American Psychoanalytic Association: part I. Prediction of Improvement in medical treatment for depression: using self-report measures of Erikson's stages.
    Kaplan M; Stukenberg K; Kruty M
    J Am Psychoanal Assoc; 2008 Dec; 56(4):1348-51. PubMed ID: 19037132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.